Fresenius Kabi
Clinical trials sponsored by Fresenius Kabi, explained in plain language.
-
New study checks if fat emulsion prevents deficiency in sick infants
Disease control Recruiting nowThis study looks at whether Omegaven, a special fat emulsion given through an IV, is safe for children under 18 who have developed liver problems from long-term IV feeding. The main goal is to see how many children develop a lack of essential fatty acids, which can cause skin iss…
Sponsor: Fresenius Kabi • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New study checks IV fat emulsion for safety in Long-Term nutrition patients
Disease control Recruiting nowThis study looks at the safety of SMOFlipid, a fat emulsion given through an IV, in children and adults who need IV nutrition for 8 weeks or longer. The goal is to see how often patients develop essential fatty acid deficiency or a liver problem called parenteral nutrition-associ…
Phase: PHASE4 • Sponsor: Fresenius Kabi • Aim: Disease control
Last updated May 15, 2026 11:55 UTC